Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Centessa Pharmaceuticals Q2 EPS $(0.69) Down From $(0.65) YoY

Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.69) per share. This is a 6.15 percent decrease over losses of $(0.65) per share from the same period last year.
byBenzinga Newsdesk
August 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.69) per share. This is a 6.15 percent decrease over losses of $(0.65) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts